Acknowledgments The authors thank colleagues and mentors for their feedback on the conceptual development of PDM and for their insights during the manuscript revision process
By ascending doses gradually0.25 mg, then 0.5 mg, then 1.0 mg, and potentially higheryou give your gastrointestinal tract and metabolic pathways time to rebalance while your brain's satiety centers adapt to new signaling patterns
Microdosing semaglutide, using doses below the standard therapeutic range, has gained attention as an approach for people who want modest appetite suppression with minimal side effects
Emergency management protocols for accidental pediatric medication ingestion: Niacin considerations
Scientists knew that retatrutide held promise, but when those astonishing preliminary results were shared in 2023, excitement spilled out from labs into the public
Research published in The Lancet examining GLP-1 receptor agonist eligibility across 99 countries found that eligibility varies dramatically based on which BMI thresholds are used